Jenifer Espasandín-Domínguez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jenifer Espasandín-Domínguez has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Francisco Gude
Research Methodology Group, Institute of Biomedical Research of Santiago (IDIS), University of Santiago de Compostela (USC), 15706 Santiago de Compostela, Spain
5 shared publications Carmen Cadarso-Suárez
University of Santiago de Compostela
4 shared publications- Carmen Cadarso-Suárez
Coordinador del programa de fellowship de ginecologia oncologica. Centro Médico Docente La Trinidad
3 shared publications Francisco Gude
Hospital Clínico Universitario de Santiago de Compostela
2 shared publications- Ipek Guler
University of Santiago de Compostela
2 shared publications Oscar Lado-Baleato
University of Santiago de Compostela
2 shared publications
Latest Publications
- 1 January 2022
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 15 (1) , 16-24
Longer-Term Results of a Universal Electronic Consultation Program at the Cardiology Department of a Galician Healthcare Area
Background: Telemedicine models play a key role in organizing the growing demand for care and healthcare accessibility, but there are no described longer-term results in health care. Our objective is to assess the longer-term results (delay time in care, accessibility, and hospital admissions) of an electronic consultation (e-consultation) outpatient care program. Methods: Epidemiological and clinical data were obtained from the 41 258 patients referred by primary care to the cardiology department from January 1, 2010, to December 31, 2019. Until 2012, all patients were attended in an in-person consultation (2010–2012). In 2013, we instituted an e-consultation program (2013-2019) for all primary care referrals to cardiologists that preceded patients’ in-person consultations when considered. We used an interrupted time series regression approach to investigate the impact of the e-consultation on (1) delay time (days) in care and (2) hospital admissions. We also analyzed (3) total number and referral rate (population-adjusted referred rate) in both periods (in-person consultation and e-consultation), and (4) the accessibility was measured as number of consultations and variation according to distance from municipality and reference hospital. Results: During the e-consultation, the demand increased (7.2±2.4% versus 10.1±4.8% per 1000 inhabitants, P P P P =0.874). Conclusions: Implementing e-consultations in the outpatient management model may improve accessibility of care for patients furthest from the referral hospital. After e-consultations were implemented, the upward trend of hospital admissions observed during the in-person consultation period was stabilized with a slight downward trend.
- 1 January 2022
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 15 (1) , 16-24
Longer-Term Results of a Universal Electronic Consultation Program at the Cardiology Department of a Galician Healthcare Area
Background: Telemedicine models play a key role in organizing the growing demand for care and healthcare accessibility, but there are no described longer-term results in health care. Our objective is to assess the longer-term results (delay time in care, accessibility, and hospital admissions) of an electronic consultation (e-consultation) outpatient care program. Methods: Epidemiological and clinical data were obtained from the 41 258 patients referred by primary care to the cardiology department from January 1, 2010, to December 31, 2019. Until 2012, all patients were attended in an in-person consultation (2010–2012). In 2013, we instituted an e-consultation program (2013-2019) for all primary care referrals to cardiologists that preceded patients’ in-person consultations when considered. We used an interrupted time series regression approach to investigate the impact of the e-consultation on (1) delay time (days) in care and (2) hospital admissions. We also analyzed (3) total number and referral rate (population-adjusted referred rate) in both periods (in-person consultation and e-consultation), and (4) the accessibility was measured as number of consultations and variation according to distance from municipality and reference hospital. Results: During the e-consultation, the demand increased (7.2±2.4% versus 10.1±4.8% per 1000 inhabitants, P P P P =0.874). Conclusions: Implementing e-consultations in the outpatient management model may improve accessibility of care for patients furthest from the referral hospital. After e-consultations were implemented, the upward trend of hospital admissions observed during the in-person consultation period was stabilized with a slight downward trend.
- Open Access
- 8 December 2020
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 50 (1) , 64-74
Development and validation of a prognostic model based on comorbidities to predict COVID-19 severity: a population-based study
Background: The prognosis of patients with COVID-19 infection is uncertain. We derived and validated a new risk model for predicting progression to disease severity, hospitalization, admission to intensive care unit (ICU) and mortality in patients with COVID-19 infection (Gal-COVID-19 scores). Methods: This is a retrospective cohort study of patients with COVID-19 infection confirmed by reverse transcription polymerase chain reaction (RT-PCR) in Galicia, Spain. Data were extracted from electronic health records of patients, including age, sex and comorbidities according to International Classification of Primary Care codes (ICPC-2). Logistic regression models were used to estimate the probability of disease severity. Calibration and discrimination were evaluated to assess model performance. Results: The incidence of infection was 0.39% (10 454 patients). A total of 2492 patients (23.8%) required hospitalization, 284 (2.7%) were admitted to the ICU and 544 (5.2%) died. The variables included in the models to predict severity included age, gender and chronic comorbidities such as cardiovascular disease, diabetes, obesity, hypertension, chronic obstructive pulmonary disease, asthma, liver disease, chronic kidney disease and haematological cancer. The models demonstrated a fair–good fit for predicting hospitalization {AUC [area under the receiver operating characteristics (ROC) curve] 0.77 [95% confidence interval (CI) 0.76, 0.78]}, admission to ICU [AUC 0.83 (95%CI 0.81, 0.85)] and death [AUC 0.89 (95%CI 0.88, 0.90)]. Conclusions: The Gal-COVID-19 scores provide risk estimates for predicting severity in COVID-19 patients. The ability to predict disease severity may help clinicians prioritize high-risk patients and facilitate the decision making of health authorities.
- 8 December 2020
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 50 (1) , 64-74
Open AccessDevelopment and validation of a prognostic model based on comorbidities to predict COVID-19 severity: a population-based study
Background: The prognosis of patients with COVID-19 infection is uncertain. We derived and validated a new risk model for predicting progression to disease severity, hospitalization, admission to intensive care unit (ICU) and mortality in patients with COVID-19 infection (Gal-COVID-19 scores). Methods: This is a retrospective cohort study of patients with COVID-19 infection confirmed by reverse transcription polymerase chain reaction (RT-PCR) in Galicia, Spain. Data were extracted from electronic health records of patients, including age, sex and comorbidities according to International Classification of Primary Care codes (ICPC-2). Logistic regression models were used to estimate the probability of disease severity. Calibration and discrimination were evaluated to assess model performance. Results: The incidence of infection was 0.39% (10 454 patients). A total of 2492 patients (23.8%) required hospitalization, 284 (2.7%) were admitted to the ICU and 544 (5.2%) died. The variables included in the models to predict severity included age, gender and chronic comorbidities such as cardiovascular disease, diabetes, obesity, hypertension, chronic obstructive pulmonary disease, asthma, liver disease, chronic kidney disease and haematological cancer. The models demonstrated a fair–good fit for predicting hospitalization {AUC [area under the receiver operating characteristics (ROC) curve] 0.77 [95% confidence interval (CI) 0.76, 0.78]}, admission to ICU [AUC 0.83 (95%CI 0.81, 0.85)] and death [AUC 0.89 (95%CI 0.88, 0.90)]. Conclusions: The Gal-COVID-19 scores provide risk estimates for predicting severity in COVID-19 patients. The ability to predict disease severity may help clinicians prioritize high-risk patients and facilitate the decision making of health authorities.
- 7 October 2019
- Published by Wiley in Statistics in Medicine
- Vol. 38 (27) , 5161-5181
Assessing the relationship between markers of glycemic control through flexible copula regression models
Summary: Glycated haemoglobin (HbA1c) is a sensitive marker of blood glucose in patients with diabetes. However, levels can vary considerably, even amongst individuals with similar mean blood glucose concentrations. Other glycated proteins, such as fructosamine, can also act as blood sugar markers, but estimating HbA1c and fructosamine via independent models may lead to errors of interpretation regarding disease severity. From a clinical standpoint, it would be of great interest to know the factors that affect the mean concentration of both HbA1c and fructosamine, which influence the variability in the concentrations of these glycated markers and cause HbA1c/fructosamine discordance. Flexible models are required to illustrate the behaviour of these variables as well as the association between them. This work reviews existing models that might serve in this regard. Flexible copula regression models using splines were used to provide a better understanding of the behaviour of both glycated proteins and the relationship between them under the possible influence of different covariates. This work shows the usefulness of this type of models in practise and provides a basis for their clinical interpretation by means of an understandable case study. Ultimately, to better understand the effects of each continuous covariate, they are represented at the true scale of the response variables.
- 7 October 2019
- Published by Wiley in Statistics in Medicine
- Vol. 38 (27) , 5161-5181
Assessing the relationship between markers of glycemic control through flexible copula regression models
Summary: Glycated haemoglobin (HbA1c) is a sensitive marker of blood glucose in patients with diabetes. However, levels can vary considerably, even amongst individuals with similar mean blood glucose concentrations. Other glycated proteins, such as fructosamine, can also act as blood sugar markers, but estimating HbA1c and fructosamine via independent models may lead to errors of interpretation regarding disease severity. From a clinical standpoint, it would be of great interest to know the factors that affect the mean concentration of both HbA1c and fructosamine, which influence the variability in the concentrations of these glycated markers and cause HbA1c/fructosamine discordance. Flexible models are required to illustrate the behaviour of these variables as well as the association between them. This work reviews existing models that might serve in this regard. Flexible copula regression models using splines were used to provide a better understanding of the behaviour of both glycated proteins and the relationship between them under the possible influence of different covariates. This work shows the usefulness of this type of models in practise and provides a basis for their clinical interpretation by means of an understandable case study. Ultimately, to better understand the effects of each continuous covariate, they are represented at the true scale of the response variables.
- Open Access
Data Science in Biomedicine
We highlight the role of Data Science in Biomedicine. Our manuscript goes from the general to the particular, presenting a global definition of Data Science and showing the trend for this discipline together with the terms of cloud computing and big data. In addition, since Data Science is mostly related to areas like economy or business, we describe its importance in biomedicine. Biomedical Data Science (BDS) presents the challenge of dealing with data coming from a range of biological and medical research, focusing on methodologies to advance the biomedical science discoveries, in an interdisciplinary context.
Open AccessData Science in Biomedicine
We highlight the role of Data Science in Biomedicine. Our manuscript goes from the general to the particular, presenting a global definition of Data Science and showing the trend for this discipline together with the terms of cloud computing and big data. In addition, since Data Science is mostly related to areas like economy or business, we describe its importance in biomedicine. Biomedical Data Science (BDS) presents the challenge of dealing with data coming from a range of biological and medical research, focusing on methodologies to advance the biomedical science discoveries, in an interdisciplinary context.
- Open Access
- 1 April 2018
- Published by Elsevier in Spatial Statistics
- Vol. 24, 1-13
Geographical differences in blood potassium detected using a structured additive distributional regression model
- 1 April 2018
- Published by Elsevier in Spatial Statistics
- Vol. 24, 1-13
Open AccessGeographical differences in blood potassium detected using a structured additive distributional regression model
- 1 March 2018
- Published by Springer Nature
- p. 135-146
Bivariate Copula Additive Models for Location, Scale and Shape with Applications in Biomedicine
- 1 March 2018
- Published by Springer Nature
- p. 135-146
Bivariate Copula Additive Models for Location, Scale and Shape with Applications in Biomedicine
- 7 July 2017
- Published by Springer Nature
- p. 586-599
Applying Spatial Copula Additive Regression to Breast Cancer Screening Data
- 7 July 2017
- Published by Springer Nature
- p. 586-599
Applying Spatial Copula Additive Regression to Breast Cancer Screening Data
- Open Access
- 1 January 2015
- Published by Elsevier in Procedia Environmental Sciences
- Vol. 27, 119-122
Predictive Performance of Geoadditive Survival Models to Study Geographical Patterns in Coronary Heart Disease
- 1 January 2015
- Published by Elsevier in Procedia Environmental Sciences
- Vol. 27, 119-122
Open AccessPredictive Performance of Geoadditive Survival Models to Study Geographical Patterns in Coronary Heart Disease
- Open Access
- 1 January 2015
- Published by Elsevier in Procedia Environmental Sciences
- Vol. 27, 94-97
Spatial Patterns in the Rate of Alcohol Withdrawal Syndrome in Galicia (Spain)
- 1 January 2015
- Published by Elsevier in Procedia Environmental Sciences
- Vol. 27, 94-97
Open AccessSpatial Patterns in the Rate of Alcohol Withdrawal Syndrome in Galicia (Spain)